S. Yendluri

发表

AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma.

D. Deen, T. Ozawa, K. Jooss, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis

S. Bartz, D. Johns, S. Yendluri, 2015, Journal of Cardiovascular Translational Research.

Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectors.

K. Jooss, T. Harding, P. Dickinson, 2006, Human gene therapy.

Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.

Sarah L. Williams, D. Bussiere, X. Ling, 2021, Journal of medicinal chemistry.

Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension

S. Bartz, D. Cully, Marianne E. Eybye, 2014, Hypertension Research.

Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B

G. Veres, J. Mcarthur, A. Subramanian, 2004, Gene Therapy.

Development and characterization of a cell line for large‐scale, serum‐free production of recombinant adeno‐associated viral vectors

B. Donahue, T. Harding, R. Snyder, 2004, The journal of gene medicine.

Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk

K. Mansfield, W. Zhong, M. Fenaux, 2016, Antimicrobial Agents and Chemotherapy.

Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy.

S. Nicklin, L. Denby, B. Donahue, 2003, Journal of molecular and cellular cardiology.

Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors

K. Spindler, Y. Ge, K. Jooss, 2009, Journal of Virology.

Title : A novel immune-competent murine tumor model for the evaluation of conditionally replication-competent ( oncolytic ) murine adenoviral vectors

K. Spindler, Y. Ge, K. Jooss, 2009 .

Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey[S]

S. Bartz, Shirly Pinto, D. McLaren, 2016, Journal of Lipid Research.

siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids[S]

S. Bartz, Kenny K. Wong, L. Mitnaul, 2011, Journal of Lipid Research.

The N-terminus of the Begomovirus nuclear shuttle protein (BV1) determines virulence or avirulence in Phaseolus vulgaris.

R. Gilbertson, M. Sudarshana, Y. Zhou, 2007, Molecular plant-microbe interactions : MPMI.

Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression

L. Hawkins, Y. Ge, K. Jooss, 2008, Cancer Gene Therapy.